Kang Sheng Bao to Develop Immune System Diagnostic Test for SuperNova

Shenzhen Kang Sheng Bao Bio-Technology (深圳康生保生物技术有限公司) has signed an agreement with SuperNova Diagnostics®, a Washington DC development stage company, giving KSB the responsibility to develop, manufacture and market diagnostic products that measure neopterin. Neopterin is a biomarker of immune system activity. KSB will use SuperNova’s AmpCrystal® platform. Two weeks ago, KSB and SuperNova announced KSB had licensed China rights for SuperNova’s platform. More details.... Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});